Clinical trialsRegistry-verified

Hammersmith Medicines Research

London

Treatment & access

  • Treatments offered5-MeO-DMT (BPL-003, intranasal: clinical trial)
  • Access routeThrough a clinical trial
  • Cost & coverage (registry status)Free within clinical trial
  • Websitehttps://www.hmrlondon.com/

About this provider

Compiled from the registry data on this page.

Hammersmith Medicines Research in London, United Kingdom, is listed as a clinical trial site. The entry concerns a clinical trial of intranasal 5-MeO-DMT (BPL-003) for treatment-resistant depression, registered on ClinicalTrials.gov under identifier NCT05660642, which is the registry source cited by this record. Access is through participation in the clinical trial, and treatment is free within the clinical trial. No separate pricing or reimbursement information is recorded for this entry. The record was last verified on 2026-07-31.

Services & programs

Programs & studies

ProgramKindStatus
Clinical trial (NCT05660642)
Auto-linked from the record’s registry sources; status refreshed from ClinicalTrials.gov.
Key entry criteria by protocol: age 18–75 · patients only (no healthy volunteers). Full inclusion and exclusion criteria on the registry. The research team makes the final eligibility decision.
clinical trialRecruiting

Verification

Re-checked every 90 days · how we verify and report corrections

Check your fit & enquire

Check my fit & enquire

Free 2-minute pre-screening in your browser · your summary goes only to Hammersmith Medicines Research, with your consent.

What to prepare before you enquire

  • A referral or the contact details of your treating clinician
  • A list of medications you have tried (names, doses, duration)
  • A short diagnosis summary or discharge letters

The research team confirms eligibility against your medical records at a screening visit.

Send documents directly to the provider when they reply. We never ask you to upload medical records.